Hanrui Zheng Selected Research

Diabetic Foot

1/2022

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Hanrui Zheng Research Topics

Disease

4	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/2024 - 01/2018
4	Neoplasms (Cancer) 01/2022 - 01/2017
2	Colorectal Neoplasms (Colorectal Cancer) 04/2024 - 01/2015
2	Type 2 Diabetes Mellitus (MODY) 01/2023 - 01/2021
2	Breast Neoplasms (Breast Cancer) 01/2023 - 06/2022
2	Esophageal Squamous Cell Carcinoma 01/2023 - 12/2019
2	Carcinoma (Carcinomatosis) 01/2022 - 01/2022
2	Hepatocellular Carcinoma (Hepatoma) 01/2021 - 04/2020
2	Stomach Neoplasms (Stomach Cancer) 01/2021 - 11/2016
2	Adenocarcinoma 01/2020 - 11/2016
1	Diabetic Ketoacidosis (Ketoacidosis, Diabetic) 01/2023
1	Diabetes Mellitus 01/2022
1	Esophageal Neoplasms (Esophageal Cancer) 01/2022
1	Ulcer 01/2022
1	Diabetic Foot 01/2022
1	Disease Progression 01/2022
1	Infections 01/2021
1	Obesity 01/2021
1	Overweight 01/2021
1	Body Weight (Weight, Body) 01/2021
1	Nasopharyngeal Carcinoma 02/2020
1	Pancreatic Neoplasms (Pancreatic Cancer) 01/2020
1	Parkinson Disease (Parkinson's Disease) 01/2019
1	Adenocarcinoma of Lung 12/2018
1	Ovarian Neoplasms (Ovarian Cancer) 12/2018
1	Glioblastoma (Glioblastoma Multiforme) 12/2018
1	Malignant Mesothelioma 01/2017

Drug/Important Bio-Agent (IBA)

4	Cisplatin (Platino)FDA LinkGeneric 01/2023 - 11/2016
4	Fluorouracil (Carac)FDA LinkGeneric 01/2023 - 11/2016
2	Glucose (Dextrose)FDA LinkGeneric 01/2023 - 01/2021
2	SodiumIBA 01/2023 - 01/2021
2	Sodium-Glucose Transporter 2 InhibitorsIBA 01/2023 - 01/2021
2	avelumabIBA 01/2022 - 01/2022
2	Sorafenib (BAY 43-9006)FDA Link 01/2021 - 04/2020
2	Bevacizumab (Avastin)FDA Link 01/2021 - 01/2017
2	Leucovorin (Folinic Acid)FDA Link 01/2020 - 11/2016
2	Irinotecan (Camptosar)FDA LinkGeneric 01/2020 - 11/2016
1	HMPL-013IBA 04/2024
1	B7-H1 AntigenIBA 01/2023
1	toripalimabIBA 01/2023
1	trastuzumab deruxtecanIBA 01/2023
1	abemaciclibIBA 06/2022
1	Hormones (Hormone)IBA 06/2022
1	Fulvestrant (Faslodex)FDA Link 06/2022
1	Low-Molecular-Weight Heparin (Heparin, Low Molecular Weight)IBA 01/2022
1	camrelizumabIBA 01/2022
1	pembrolizumabIBA 01/2022
1	Heparin (Liquaemin)FDA LinkGeneric 01/2022
1	Hyaluronic Acid (Hyaluronan)IBA 01/2022
1	LigandsIBA 01/2022
1	atezolizumabIBA 01/2021
1	theasinensin AIBA 01/2021
1	RamucirumabIBA 04/2020
1	Fetal Proteins (Fetoprotein)IBA 04/2020
1	Gemcitabine FDA Link 02/2020
1	Oxaliplatin (Eloxatin)FDA LinkGeneric 01/2020
1	olaparibIBA 01/2020
1	mangiferinIBA 12/2018
1	Growth Factor ReceptorsIBA 01/2018
1	Erlotinib Hydrochloride (CP 358,774)FDA Link 01/2018
1	Tyrosine Kinase InhibitorsIBA 01/2018
1	Pemetrexed (MTA)FDA Link 01/2017
1	Epirubicin (Ellence)FDA LinkGeneric 11/2016
1	Capecitabine (Xeloda)FDA Link 11/2016
1	Monoclonal AntibodiesIBA 01/2015
1	Cetuximab (Erbitux)FDA Link 01/2015

Therapy/Procedure

8	Drug Therapy (Chemotherapy) 01/2024 - 01/2018
8	Therapeutics 01/2023 - 01/2015
2	Glycemic Control 01/2023 - 01/2021
1	Neoadjuvant Therapy 12/2019
1	Islets of Langerhans Transplantation 01/2019
1	Transplantation 01/2019
1	Liver Transplantation 01/2019
1	Radiotherapy 12/2018